Developments in Pain Imaging
Journal Title: Nuclear Medicine Seminars - Year 2020, Vol 6, Issue 1
Abstract
In order to determine the etiology of chronic pain, radiological imaging tools like computed tomography (CT) and magnetic resonance imaging (MRI) are usually used. Except for the anatomical data that the radiological imaging methods provide, there are nuclear medicine imaging methods like bone scintigraphy and positron emission tomography (PET) which are used to demonstrate metabolic changes in the bone, joint and neighbouring soft tissue which may cause pain. Recently, hybrid imaging methods combining anatomical and metabolic imaging like single photon emission computed tomography (SPECT)/CT and PET/MR have been introduced. In the last decades, imaging with higher resolution and providing anatomical localisation have been possible thanks to bone scintigraphy performed with hybrid SPECT/CT. This is why clinical studies have been performed especially about the role of bone SPECT/CT in the evaluation of pain originating from vertebra. The major limitation of the studies with bone SPECT/CT is that the uptake of radiopharmaceutical is limited to increase in osteoblastic activity and that changes like inflammation cannot be diagnosed. So, PET imaging combined with MR and performed with radiopharmaceuticals imaging different metabolic pathways come forward. PET/MR studies performed with the most commonly used radiopharmaceutical, F-18-FDG, come first among the studies on PET/MR in pain imaging. While F-18-FDG PET/MR imaging provides anatomical abnormalities of the joint with MRI component and hypermetabolic/inflammatory pathologies with PET component, it is a promising imaging tool for diagnosing the causes of chronic pain. Another PET radiopharmaceutical in pain imaging is F-18-sodyum fluoride (NaF). However, data about its use in degenerative bone diseases is limited. It has been reported that metabolic changes can be detected before MRI changes appear. Sigma-1 receptor (S1R) is especially localized in the endoplasmic reticulum as a signal modulating receptor which plays role in the pathophysiology of many neurological diseases, mainly neuropathic pain, is found extensively in the central nervous system. F-18- FTC-146 [6-(3-(18F)fluoropropyl)-3-(2-(azepan-1)ethyl)benzo(d)thiazol-2] is a radiopharmaceutical which targets this receptor and binds with high affinity. Because it is a very recently developed radiopharmaceutical, the available findings are needed to be supported by further clinical trials. Already existing results show that this imaging method is a promising tool in pain imaging.
Authors and Affiliations
Çiğdem Soydal, Mine Araz
Keywords
Related Articles
- EP ID EP685342
- DOI 10.4274/nts.galenos.2020.0001
- Views 150
- Downloads 0
F-18 FDG PET/CT Practice Guideline in Oncology: Assesment of Treatment Response
Assessing response to treatment is an important parameter in oncology practice and there is a growing body of evidence for use of F-18 fludeoxyglucose (FDG) positron emission tomography/computerized tomography (PET/CT) t...
Renal Cortical Scintigraphy Procedure Guideline
This guideline is the updated version of TNTD renal cortical scintigraphy guideline published in 2001. It includes the current recommended patient doses and patient dosimetry according to international guidelines.
Radionuclide Methods for Pain Palliation
Bone is a common metastatic site of cancer. Bone metastasis reduces life expectancy and results in serious symptoms and complications such as bone pain, pathological fractures, spinal cord compression, and malignant hype...
Current Good Manufacturing Practice for Radiopharmaceutical Products (GMPR)
Radiopharmaceutical products are classified as specialty medicinal products containing radionuclides whose half-lives range from a few minutes to several days, and therefore they form the basis of the same regulations as...
Procedure Guideline for Lymphoscintigraphy and Sentinel Lymph Node: Malignant Melanoma
Malignant melanoma is still among the most fatal cancers worldwide with increasing incidence. Lymphoscintigraphy and gamma probe guided sentinel lymph node detection is an established procedure which has a great impact i...